Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-10

FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Rhodes Pharmaceuticals L.P.)

View source ↗

Summary

The FDA approved Rhodes Pharmaceuticals L.P.'s supplemental application for Oxycodone and Acetaminophen, a fixed-dose opioid analgesic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXYCODONE AND ACETAMINOPHEN (oxycodone and acetaminophen)

Snippet

SUPPL AP for OXYCODONE AND ACETAMINOPHEN (OXYCODONE AND ACETAMINOPHEN)